Drawing for MSD

USPTO serial 79443795

MSD

Reviewed by CopyMark Law Group

Status 640Office Action
Filing date
Status date
Registration date
—
Examiner
VAGHANI, MAYUR C
Law office
TMO LAW OFFICE 124

What this means

The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.

Status 640: Status 640 means the examining attorney has prepared a non-final Office Action but it has not been mailed or e-mailed yet. The action should appear in TSDR soon, and a response deadline will start once it is issued.

Need help with MSD?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Christina S. Loza

Christina S. Loza LOZA & LOZA, LLP305 N. Second Ave., #127Upland, CA 91786United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of autoimmune, bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, psychiatric, pulmonary, renal, respiratory, urological, viral, infectious, fungal, bacterial, and parasitic diseases and disorders for human and veterinary use; human vaccine preparations; vaccines for veterinary use, namely, for the treatment of ruminants, porcines, equines, companion animals, aquaculture, and poultry; medicated supplements for foodstuffs for animalsACTIVE—
010Surgical apparatus and instruments for medical or veterinary use; medical instruments and apparatus for treating autoimmune, bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, psychiatric, pulmonary, renal, respiratory, urological, viral, infectious, fungal, bacterial, and parasitic diseases and disorders; inhalers for medical purposes, sold empty; injection and medical or veterinary infusion devices for administering pharmaceuticals; veterinary apparatus and instruments for dispensing pharmaceutical products, namely, drenching guns for animals and livestock, veterinary vaccine applicators, veterinary infusers and injectors, veterinary dosing devices, sutures, and temperature measuring systems for veterinary useACTIVE—
035Business support services to start-up companies in the pharmaceutical, healthcare, veterinary, and biomedical fields by providing workspace containing technology equipment; business information services in the fields of healthcare, pharmaceuticals, medicine, and animal health; providing incentive award programs through issuance and processing of loyalty points for purchase of a company's goods and services in the fields of healthcare, pharmaceuticals, medicine, and animal health; administration of a program for enabling participants to obtain discounts on products and services in the fields of healthcare, pharmaceuticals, medicine, and animal health; provision of business, marketing, product sales and commercial information relating to pharmaceutical, medical, veterinary and healthcare products via a global communications network; retail, wholesale, and online retail store services featuring vaccines, pharmaceuticals, healthcare products, medicines, and veterinary products; distribution of advertising, marketing and promotional material in the fields of healthcare, pharmaceuticals, medicines, and animal health; business research and data analysis in the field of pharmaceutical drug developmentACTIVE—
041Educational services, namely, conducting programs in the fields of medicine, healthcare, pharmaceuticals, and animal health, and distribution of educational materials in connection therewithACTIVE—
044Providing information in the fields of healthcare, pharmaceuticals, medicines, and animal health, including via a website; charitable services, namely, providing medical, veterinary and healthcare services in the nature of providing medication use and management information and mental health and wellness information to patients and caregivers; veterinary servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (ARAA): This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.

DateCodeEventWhat it means
Oct 1, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 1, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 1, 2026CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Oct 1, 2026COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Aug 20, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED—
May 15, 2026RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
May 14, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 13, 2026DOCKASSIGNED TO EXAMINER—
Mar 12, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 12, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 10, 2026LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Feb 12, 2026SDRCSN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB—

Frequently asked questions

Related guidance